SEARCH

SEARCH BY CITATION

References

  • 1
    Westermann J, Pabst R. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today 1990; 11 : 40610.
  • 2
    Rosenberg YJ, Janossy G. The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections. Semin Immunol 1999; 11 : 13954.
  • 3
    Morton BA, Ramey WG, Paderon H, Miller RE. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer. Cancer Res 1986; 46 : 21216.
  • 4
    Khuri N, Jothy SP, Shibata HR. Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients. Can J Surg 1989; 32 : 236.
  • 5
    Farzad Z, Cochran AJ, McBride WH, Gray JD, Wong V, Morton DL. Lymphocyte subset alterations in nodes regional to human melanoma. Cancer Res 1990; 50 : 35858.
  • 6
    Rubbert A, Manger B, Lang N, Kalden JR, Platzer E. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer. Int J Cancer 1991; 49 : 2531.
  • 7
    Adachi W, Sugenoya A, Iida F. Immune competent cells of regional lymph nodes in colorectal cancer patients. I. Flow cytometric analysis of lymphocyte subpopulation. J Surg Oncol 1991; 46 : 11016.
  • 8
    Bryan CF, Eastman PJ, Conner JB, Baier KA, Durham JB. Clinical utility of a lymph node normal range obtained by flow cytometry. Ann N Y Acad Sci 1993; 677 : 4046.
  • 9
    Lores-Vazquez B, Pacheco-Carracedo M, Oliver-Morales J, Parada-Gonzalez P, Gambon-Deza F. Lymphocyte subpopulations of regional lymph nodes in human colon and gastric adenocarcinomas. Cancer Immunol Immunother 1996; 42 : 33942.
  • 10
    Takenoyama M, Yasumoto K, Harada M, Matsuzaki G, Ishida T, Sugimachi K, Nomoto K. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer. Immunobiology 1996; 195 : 14051.
  • 11
    Vidal-Rubio B, Sanchez-Carril M, Oliver-Morales J, Gonzalez-Femandez AA, Gambon-Deza F. Changes in human lymphocyte subpopulations in tonsils and regional lymph nodes of human head and neck squamous carcinoma compared to control lymph nodes. BMC Immunol 2001; 2 : 2.
  • 12
    Di Girolamo V, Laguens RP, Coronato S, Salas M, Spinelli O, Portiansky E, Laguens G. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors. J Exp Clin Cancer Res 2000; 19 : 1559.
  • 13
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol 2001; 81 : 42432.
  • 14
    Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2 : 81622.
  • 15
    Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182 : 1832.
  • 16
    Karim M, Bushell A. Wood K Regulatory T cells in transplantation. Curr Opin Immunol 2002; 14 : 58491.
  • 17
    Shevac EM. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2 : 389400.
  • 18
    Levings MK, Sangregorio R, Roncarolo MG. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193 : 1295302.
  • 19
    Woo EY, Chu CS, Goletz TJ et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001; 61 : 476672.
  • 20
    Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167 : 124553.
  • 21
    Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E. Characterization of human CD25+CD4+ T cells in thymus, cord and adult blood. Immunology 2002; 106 : 1909.
  • 22
    Liyanage UK, Moore TT, Joo HG et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169 : 275661.
  • 23
    Fattorossi A, Battaglia A, Pierelli L et al. Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation. Cancer Immunol Immunother 2001; 49 : 6418.
  • 24
    Fattorossi A, Battaglia A, Ferlini C. Lymphocyte activation associated antigens. Meth Cell Biol 2001; 63 : 43363.
  • 25
    Fattorossi A, Battaglia A, Malinconico P et al. Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells. Exp Cell Res 2002; 280 : 10718.
  • 26
    Reinhardt C, Melms A. Skewed TCRVβ repertoire in human thymus persists after thymic emigration: influence of genomic imposition, thymic maturation and environmental challenge on human TCRV β usage in vivo. Immunobiology 1998; 199 : 7486.
  • 27
    Weinberg AD, Vella AT, Croft M. OX-40: life beyond the effector T cell stage. Semin Immunol 1998; 10 : 47180.
  • 28
    De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 11-color, 13-parameter flow cytometry. identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001; 7 : 2458.
  • 29
    Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, Van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186 : 140718.
  • 30
    Metzler B, Burkhart C, Wraith DC. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. Int Immunol 1999; 11 : 66775.
  • 31
    Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334 : 395402.
  • 32
    Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 2000; 12 : 114555.
  • 33
    Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193 : 128594.
  • 34
    Stephens LA, Mottet C, Mason D, Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31 : 124754.
  • 35
    Simark-Mattsson C, Dahlgren U, Roos K. CD4+CD25+ T lymphocytes in human tonsils suppress the proliferation of CD4+CD25 tonsil cells. Scand J Immunol 2002; 55 : 60611.
  • 36
    Annunziato F, Cosmi L, Liotta F et al. Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes. J Exp Med 2002; 196 : 37987.